Author

T. Andl

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 2 Research Focus:cancer & tumor microenvironment· 2 Organism:human· 2 Approach:experimental assay· 1 Approach:statistical model· 1

Frequent Co-Authors

A. Khatib· 1 shared D. Coppola· 1 shared J. N. Soulakova· 1 shared J. Sun· 1 shared K. Ganapathy· 1 shared L. Zhou· 1 shared M. F. Hasan· 1 shared R. Chakrabarti· 1 shared

Activity by Year

2020-2021 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 29 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

A. Khatib

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

BRAF inhibitors reprogram cancer-associated fibroblasts to drive matrix remodeling and therapeutic escape in melanoma

T. Liu, L. Zhou, Y. Xiao, T. Andl, Y. Zhang

This study shows BRAF inhibitors reprogram cancer-associated fibroblasts to promote matrix remodeling and resistance to therapy in melanoma by enhancing β-catenin signaling and POSTN expression.

bioRxiv · Feb 18, 2021Cancer Biology

LncRNA PAINT is Associated with Aggressive Prostate Cancer and Dysregulation of Slug and Related Genes

M. F. Hasan, K. Ganapathy, J. Sun, A. Khatib, T. Andl, J. N. Soulakova, D. Coppola, W. i. Zhang, R. Chakrabarti

This study identifies PAINT as an oncogenic lncRNA in prostate cancer that promotes progression by regulating EMT, apoptosis, and drug resistance.

bioRxiv · Oct 29, 2020 · PreprintCancer Biology